Is there a general autoantibody signature for cancer?LUDWIG, Nicole; KELLER, Andreas; LEIDINGER, Petra et al.European journal of cancer (1990). 2012, Vol 48, Num 15, pp 2451-2461, issn 0959-8049, 11 p.Article

Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancerHARALDSDOTTIR, Kristin H; IVARSSON, Kjell; JANSNER, Karin et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 6, pp 847-856, issn 0340-7004, 10 p.Article

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancerPERRONE, Giuseppe; ADELCHI RUFFINI, Pier; GIORDANI, Paolo et al.European journal of cancer (1990). 2008, Vol 44, Num 13, pp 1875-1882, issn 0959-8049, 8 p.Article

Analysis of the autoantibody repertoire in Burkitt's lymphoma patients: frequent response against the transcription factor ATF-2KERSTEN, Christian; DELABIE, Jan; GAUDERNACK, Gustav et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 12, pp 1119-1126, issn 0340-7004, 8 p.Article

Using macrophage activation to augment immunotherapy of established tumoursFRIDLENDER, Z. G; JASSAR, A; MISHALIAN, I et al.British journal of cancer. 2013, Vol 108, Num 6, pp 1288-1297, issn 0007-0920, 10 p.Article

Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathwayDI CARLO, Emma; CAPPELLO, Paola; SORRENTINO, Carlo et al.Journal of pathology. 2005, Vol 205, Num 1, pp 82-91, issn 0022-3417, 10 p.Article

High FOXP3 + regulatory T-cell density in the sentinel lymph node is associated with downstream non-sentinel lymph-node metastasis in gastric cancerLEE, H. E; PARK, D. J; KIM, W. H et al.British journal of cancer. 2011, Vol 105, Num 3, pp 413-419, issn 0007-0920, 7 p.Article

HLA-DRB1*16-restricted recognition of myeloid cells, including CD34⁺ CML progenitor cellsEBELING, Saskia B; IVANOV, Roman; HOL, Samantha et al.British journal of haematology. 2003, Vol 121, Num 5, pp 721-729, issn 0007-1048, 9 p.Article

Gangliosides inhibit the development from monocytes to dendritic cellsWÖLFL, M; BATTEN, W. Y; POSOVSZKY, C et al.Clinical and experimental immunology (Print). 2002, Vol 130, Num 3, pp 441-448, issn 0009-9104, 8 p.Article